Ophthalmic Drugs Conference

SMi Group are thrilled to announce Europe’s leading Ophthalmic Conference: Ophthalmic Drugs, being held on the 28-29 November 2017 at the Copthorne Tara Hotel in London, UK.

Ocular disease therapy has seen a surge in innovation in areas ranging from glaucoma to macular degeneration and diabetic retinopathy. As ageing populations grow globally the need for treatment in this field has grown and is expected to reach a figure of $21 billion by the year 2022. – (Source: Business Wire – http://bit.ly/2rlECrh)

Ophthalmic Drugs will gather industry leaders to discuss the latest challenges and changes in the field of ophthalmology. Explore novel approaches to treatment, ocular medical devices, targeted drug delivery technology and real-life challenges to pre-clinical and clinical trials, to deepen your understanding of inherited ocular diseases.

‘By far the most important organs of sense are our eyes. We perceive up to 80 per cent of all impressions by means of our sight. And if other senses such as taste or smell stop working, it’s the eyes that best protect us from danger.’ – (Source: Zeiss – http://bit.ly/2tl5iua)